21 | CholesterolIBA
01/2018
-
04/2002 |
9 | LipidsIBA
01/2019
-
04/2002 |
5 | Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2019
-
03/2006 |
5 | Proteins (Proteins, Gene)FDA Link
07/2008
-
01/2004 |
4 | Hormones (Hormone)IBA
01/2018
-
01/2004 |
4 | Ezetimibe (Zetia)FDA Link
01/2018
-
03/2009 |
3 | Glyphosate (Roundup)IBA
09/2020
-
01/2016 |
3 | Pharmaceutical PreparationsIBA
03/2009
-
03/2006 |
3 | Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
07/2007
-
04/2002 |
2 | HerbicidesIBA
09/2020
-
01/2013 |
2 | AndrogensIBA
01/2018
-
01/2012 |
2 | AtrazineIBA
01/2013
-
02/2003 |
2 | Oxidoreductases (Dehydrogenase)IBA
05/2008
-
08/2006 |
2 | Interleukin-6 (Interleukin 6)IBA
02/2007
-
02/2004 |
2 | CaveolinsIBA
02/2004
-
04/2002 |
1 | SteroidsIBA
01/2018 |
1 | 2,2',3,3',4,4',5,5',6-nonabromodiphenyl etherIBA
01/2018 |
1 | Halogenated Diphenyl EthersIBA
01/2018 |
1 | 2,2',3,3',4,4',5,6,6'-nonabromodiphenyl etherIBA
01/2018 |
1 | Flame Retardants (Fire Retardants)IBA
01/2018 |
1 | LDL Receptors (LDL Receptor)IBA
01/2017 |
1 | Messenger RNA (mRNA)IBA
01/2017 |
1 | Therapeutic UsesIBA
01/2017 |
1 | Simvastatin (Zocor)FDA LinkGeneric
01/2017 |
1 | CarcinogensIBA
01/2016 |
1 | Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
08/2012 |
1 | EnzymesIBA
01/2012 |
1 | Androgen Receptors (Androgen Receptor)IBA
01/2012 |
1 | Testosterone (Sustanon)FDA Link
01/2012 |
1 | MacrolidesIBA
11/2011 |
1 | Finasteride (Propecia)FDA LinkGeneric
10/2010 |
1 | Toxic ActionsIBA
01/2010 |
1 | Caveolin 1IBA
07/2009 |
1 | Becaplermin (PDGF-BB)FDA Link
07/2009 |
1 | Mevalonic Acid (Mevalonate)IBA
03/2009 |
1 | 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA)IBA
05/2008 |
1 | ErbB Receptors (EGF Receptor)IBA
02/2007 |
1 | Coenzyme A (CoA)IBA
08/2006 |
1 | Tyrosine (L-Tyrosine)FDA Link
04/2005 |
1 | Glycoproteins (Glycoprotein)IBA
03/2004 |
1 | flotillinsIBA
02/2004 |
1 | CytokinesIBA
02/2004 |
1 | Biomarkers (Surrogate Marker)IBA
01/2004 |
1 | Epidermal Growth Factor (EGF)IBA
04/2002 |